title: Development of a high specific activity sulfur-35-labeled sulfonamide radioligand that allowed the identification of a new growth hormone secretagogue receptor.
authors.affiliation: Department of Drug Metabolism, Merck Research Laboratories, Merck & Co., Rahway, New Jersey 07065, USA.
authors.forename: D C
authors.initials: DC
authors.lastname: Dean
authors.forename: R P
authors.initials: RP
authors.lastname: Nargund
authors.forename: S S
authors.initials: SS
authors.lastname: Pong
authors.forename: L Y
authors.initials: LY
authors.lastname: Chaung
authors.forename: P
authors.initials: P
authors.lastname: Griffin
authors.forename: D G
authors.initials: DG
authors.lastname: Melillo
authors.forename: R L
authors.initials: RL
authors.lastname: Ellsworth
authors.forename: L H
authors.initials: LH
authors.lastname: Van der Ploeg
authors.forename: A A
authors.initials: AA
authors.lastname: Patchett
authors.forename: R G
authors.initials: RG
authors.lastname: Smith
mesh_terms: D000595:Amino Acid Sequence; D000818:Animals; D007211:Indoles / Q000378:metabolism; D008969:Molecular Sequence Data; D011869:Radioligand Assay; D051381:Rats; D011986:Receptors, Somatotropin / Q000378:metabolism*; D013141:Spiro Compounds / Q000378:metabolism; D013449:Sulfonamides / Q000378:metabolism*; D013462:Sulfur Radioisotopes
chemical_list: D007211:Indoles; D011986:Receptors, Somatotropin; D013141:Spiro Compounds; D013449:Sulfonamides; D013462:Sulfur Radioisotopes; C094817:ibutamoren mesylate